The influence of patient positioning on intraoperative blood loss in orthognathic surgery - a randomised controlled trial

Organizational Data

DRKS-ID:
DRKS00013348
Recruitment Status:
Recruiting ongoing
Date of registration in DRKS:
2017-11-23
Last update in DRKS:
2019-01-15
Registration type:
Prospective

Acronym/abbreviation of the study

No Entry

URL of the study

No Entry

Brief summary in lay language

In rare cases the operative adjustement of the upper and lower jaw due to a wrong bite results in an increased blood loss. If blood loss is very high, the transfusion of foreign blood is necessary. However, this is required only in the rarest cases. The lower the blood loss in this operation, the better the tolerability of the operation. Therefore, by default, many methods or drugs are used to minimize blood loss. Observations have shown that patient positioning during surgery can also affect blood loss. Studies in the field of ear, nose and throat surgery have shown that tilting a patient during operation with limbs up and leg down (so-called "reverse Trendelenburg" position) may potentially reduce intraoperative blood loss. In order to check whether this patient positioning can also reduce blood loss in the area of ​​the operative jaw adjustement, patients are operated in this position and the intraoperative blood loss is determined. The results are then compared to a control group in which the patients were operated in a flat position. The assignment into one of the two groups (flat vs. 15 degrees reverse Trendelenburg position) happens randomly.

Brief summary in scientific language

In orthognathic surgery, blood loss is a common complication due to the high perfusion of the facial region. Many concepts aim at minimizing blood loss to improve patient outcomes. [1-2] In the field of functional endoscopic sinus surgery (FESS) as well as in the field of rhinoplasty surgery, the reverse Trendelenburg Position has proved to be a, non-invasive, low-risk aid to minimize intraoperative blood loss [3-6]. The aim of the present study is to evaluate whether operating a patient in 15 degrees reverse Trendelenburg position can also reduce intraoperative blood loss in orthognathic surgery and thus improve the clinical outcome. Study design: The study is planned as a randomized, controlled trial. Inclusion Criteria: Patients aged 14 to 90 presented to the Department of Oral and Maxillofacial Surgery at the Kepler University Hospital for whom a bignathe surgical remodeling osteotomy is induced due to malocclusion (bilateral sagittal split osteotomy in combination with a Le-Fort 1 osteotomy). Exclusion criteria: Patients with genetic syndromal anomalies, patients with congenital or acquired haemorrhagic diathesis (abnormally increased tendency to bleed), patients with vascular malformations in the neck / head area, revision surgery and previously operated patients (eg patients with orofacial cleft) Patients will be informed by means of the enclosed information sheet and must give their consent to be included in the study by signature. The consultation is carried out by the on-duty senior physician, who examines the patients on the day of admission. Using the existing literature and a power analysis, a necessary number of cases of 40 vs 40 patients was calculated. Randomization takes place by means of the "sealed-envelope" technique. Shortly before surgery, the surgeon draws an envelope indicating whether the patient is being operated in a flat position or in a 15 degree reverse Trendelenburg position. Thereafter, the corresponding position of the table is adjusted by inclinometer. After the operation, the weighing of the required wipes, the measurement of the rinsing liquid and the liquid in the surgical aspirator aswell as the filling of the corresponding attached protocol are carried out by the surgeon and the assistant nurse. Thus, the intraoperative blood loss can be determined as the main target and statistically checked whether there is a significant difference between the two groups. Literatur: 1) C. Rodrigo (1995), Induced Hypotension during Anesthesia, with Special Reference to Orthognathic Surgery - Anesth Prog 42:41-58 2) G. Song, P. Yang, S. Zhu, E. Luo, G. Feng, J. Hu, J. Li, Y. Li; (2013) Tranexamic Acid reducing blood transfusion in children undergoing craniosynostosis rugery, J Craniofac Surg 24(1):299-303 3) Gan EC1, Habib AR, Rajwani A, Javer AR. Five-degree, 10-degree, and 20-degree reverse Trendelenburg position during functional endoscopic sinus surgery: a double-blind randomized controlled trial. Int Forum Allergy Rhinol. 2014 Jan;4(1):61-8 4) Ozkose M1, Baykan H2, Coşkuner İ3. The Effect of Patient Positioning on Amount of Intraoperative Bleeding in Rhinoplasty: A Randomized Controlled Trial. Aesthetic Plast Surg. 2016 Aug;40(4):453-7. 5) Hathorn IF1, Habib AR, Manji J, Javer AR. Comparing the reverse Trendelenburg and horizontal position for endoscopic sinus surgery: a randomized controlled trial. Otolaryngol Head Neck Surg. 2013 Feb;148(2):308-13. 6) Ko MT1, Chuang KC, Su CY. Multiple analyses of factors related to intraoperative blood loss and the role of reverse Trendelenburg position in endoscopic sinus surgery. Laryngoscope. 2008 Sep;118(9):1687-91

Health condition or problem studied

ICD10:
K07 - Dentofacial anomalies [including malocclusion]
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
Bilateral sagittal split osteotomy in combination with a Le-Fort 1 osteotomy: surgery in flat position (0 degree)
Arm 2:
Bilateral sagittal split osteotomy in combination with a Le-Fort 1 osteotomy: surgery in 15 degree reverse Trendelenburg position

Endpoints

Primary outcome:
Intraoperative Blood loss: After the operation, the weighing of the required wipes, the measurement of the rinsing liquid and the liquid in the surgical aspirator aswell as the filling of the corresponding attached protocol are carried out by the surgeon and the assistant nurse. Thus, the intraoperative blood loss can be determined as the main target and statistically checked whether there is a significant difference between the two groups.
Secondary outcome:
Duration of surgery, length of hospital stay, preoperative laboratory, anesthesiological parameters, transfused volume of erythrocytes, subjective visualization of the operating area by the surgeon, subjective intraoperative blood loss by surgeon

Study Design

Purpose:
Treatment
Allocation:
Randomized controlled study
Control:
  • Active control (effective treatment of control group)
Phase:
N/A
Study type:
Interventional
Mechanism of allocation concealment:
No Entry
Blinding:
No
Assignment:
Parallel
Sequence generation:
No Entry
Who is blinded:
No Entry

Recruitment

Recruitment Status:
Recruiting ongoing
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Austria
Number of study centers:
Monocenter study
Recruitment location(s):
  • University medical center Klinik für Mund-, Kiefer- und Gesichtschirurgie, Med Campus 3, Kepler Universitätsklinikum Linz

Recruitment period and number of participants

Planned study start date:
2017-11-27
Actual study start date:
2018-01-31
Planned study completion date:
No Entry
Actual Study Completion Date:
No Entry
Target Sample Size:
80
Final Sample Size:
No Entry

Inclusion Criteria

Sex:
All
Minimum Age:
14 Years
Maximum Age:
90 Years
Additional Inclusion Criteria:
Patients aged 14 to 90 presented to the Department of Oral and Maxillofacial Surgery at the Kepler University Hospital for whom a bignathe surgical remodeling osteotomy is induced due to malocclusion (bilateral sagittal split osteotomy in combination with a Le-Fort 1 osteotomy).

Exclusion Criteria

Patients with genetic syndromal anomalies, patients with congenital or acquired haemorrhagic diathesis (abnormally increased tendency to bleed), patients with vascular malformations in the neck / head area, revision surgery and previously operated patients (e.g. patients with orofacial cleft)

Addresses

Primary Sponsor

Address:
Klinik für Anästhesiologie und IntensivmedizinMed Campus IIIKepler Universitätsklinikum Linz
Prof. Dr. Jens Meier
Krankenhausstraße 9
4020 Linz
Austria
Telephone:
004357680832158
Fax:
004357680832154
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.kepleruniklinikum.at
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Klinik für Anästhesiologie und Intensivmedizin, Med Campus III, Kepler Universitätsklinikum Linz
Prof. Dr. Jens Meier
Krankenhausstraße 9
4020 Linz
Austria
Telephone:
004357680832158
Fax:
004357680832154
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.kepleruniklinikum.at

Contact for Public Queries

Address:
Klinik für Mund-, Kiefer- und Gesichtschirurgie, Med Campus III, Kepler Universitätsklinikum Linz
Dr. Raphael Stehrer
Krankenhausstraße 9
4020 Linz
Austria
Telephone:
004357680832124
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.kepleruniklinikum.at

Principal Investigator

Address:
Klinik für Anästhesiologie und Intensivmedizin, Med Campus III, Kepler Universitätsklinikum Linz
Prof. Dr. Jens Meier
Krankenhausstraße 9
4020 Linz
Austria
Telephone:
004357680832158
Fax:
004357680832154
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.kepleruniklinikum.at

Sources of Monetary or Material Support

Institutional budget, no external funding (budget of sponsor/PI)

Address:
Klinik für Anästhesiologie und IntensivmedizinMed Campus IIIKepler Universitätsklinikum Linz
Krankenhausstraße 9
4020 Linz
Austria
Telephone:
004357680832158
Fax:
004357680832154
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.kepleruniklinikum.at

Ethics Committee

Address Ethics Committee

Address:
Kepler Universitätsklinikum GmbHEthikkommission des Landes Oberösterreich [Ethikkommission des Landes Oberösterreich]
Wagner-Jauregg-Weg 15
4020 Linz
Austria
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.kepleruniklinikum.at/lehre-forschung/ethikkommission-des-landes-ooe/was-wir-tun/

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2017-10-18
Ethics committee number:
D-48-17
Vote of the Ethics Committee:
Approved
Date of the vote:
2017-11-02

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
U1111-1205-2178
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No Entry
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
No Entry
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry